Source LDPath

Source LDPath, a part of the Source BioScience group, provides flexible cellular and digital pathology services to the NHS and Private healthcare
Source BioScience, comprised of Source LDPath and Source Genomics, is an international provider of histopathology and genomics laboratory services. Source LDPath is market leading in histopathology services in the UK, supporting NHS and private healthcare increase reporting capacities and clear backlogs of cellular and molecular diagnostic pathology samples. Source LDPath provides an end-to-end clinical healthcare service from histopathology, including digital pathology and artificial intelligence (AI), through to molecular diagnostics services, and hosts a significant and growing network of over 280 specialist consultant pathologists, all registered with the Royal College of Pathologists and General Medical Council, to ensure the highest quality reporting for patients.
Histopathology solutions
Partnering with over 80 NHS Trusts and a dominating number of private healthcare departments, Source LDPath provides rapid, reliable, and flexible cellular pathology services in every discipline of histopathology. Offering scalable laboratory processing and reporting solutions tailored to the needs of your department. Source LDPath holds a team of the UK’s leading specialist consultant pathologists, led by Source LDPath’s Medical Director Professor Ian Ellis and Director of Digital Pathology Dr Alistair Robson, to ensure the highest quality reporting and service standards.
- Wet surgical specimens to report
- Wet surgical specimens to slides
- Pre-prepared slides to report
- Block to slide
- Block to report
- Investigate audit